MapLight Therapeutics MPLT
NASDAQ MPLT
$7.63 +0.19 (+2.55%)
As of: Nov 11, 2026 · 12:33 PM EST

MapLight Therapeutics (MPLT) Long-Term Investments (2024 - 2026)

Updated

Analysis

MapLight Therapeutics (MPLT) Long-Term Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - 46.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.62 Mn
Mar 31, 2026 85.09 Mn
Dec 31, 2025 147.99 Mn
Dec 31, 2024 11.38 Mn
API Access

MapLight Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=MPLT&period=max&api_key=YOUR_API_KEY